90 - Less Sugar, More Blood
The Curious Clinicians
00:00
Introduction
This chapter investigates how SGL2 inhibitors impact hemoglobin levels in heart failure patients, citing a case study where a patient's hemoglobin increased post-guideline-directed therapy. The discussion examines the mechanism of SGL2 inhibitors and their broader benefits, shedding light on the implications for hematology.
Transcript
Play full episode
